Stock Quote


Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
FDA Approves Corcept's Korlym
By: MarketMinute.com Stock News
Posted on February 21, 2012 at 18:17 PM EST

The Food and Drug Administration approved Corcept Therapeutics Inc.'s (Nasdaq: CORT) Korlym to treat high blood sugar in Cushing's Syndrome patients sending the stock price soaring $1.42 to close at $4.45.


Related Stocks:
Corcept Therapeutics, Inc.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Mortgage Rates, CD Rates & Home Equity Rates provided by Banks.com
Press Release Service provided by PRConnect.
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
 
 

Funded By